![](/img/cover-not-exists.png)
622 Efficacy and safety of peginterferon alpha-2a (40KD) [PEG] plus ribavirin [RBV] 1000/1200 mg/d in genotype 1 patients with chronic hepatitis C and ‘normal’ ALT levels
E. Zehnter, S. Mauss, C. John, R. Heyne, B. Möller, T. Lutz, B. Bokemeyer, R. Kihn, G. Moog, U. Alshuth, D. HüppeVolume:
44
Year:
2006
Language:
english
DOI:
10.1016/s0168-8278(06)80622-7
File:
PDF, 117 KB
english, 2006